DBV Technologies Announces Positive Topline Results From Phase 3 EPITOPE Trial Of Viaskin Peanut In Peanut-Allergic Toddlers

Press/Media

Period	7 Jun 2022

Media coverage

Title	DBV Technologies Announces Positive Topline Results From Phase 3 EPITOPE Trial Of Viaskin Peanut In Peanut-Allergic Toddlers
Media name/outlet	TheStreet.com
Country/Territory	United States
Date	7/06/22
URL	ct.moreover.com/?a=47931173932&p=1gw&v=1&x=SvattAgbkqG0AADseDPSMw
Persons	Kurt Hirschhorn, Hugh Sampson

Title	DBV Technologies Announces Positive Topline Results From Phase 3 EPITOPE Trial Of Viaskin Peanut In Peanut-Allergic Toddlers
Media name/outlet	MENAFN -Press Releases (English)
Country/Territory	Jordan
Date	7/06/22
Persons	Kurt Hirschhorn, Hugh Sampson